Test Details
Methodology
ANCA: indirect fluorescent antibody (IFA); MPO and PR3: Multiplex Flow Immunoassay
Result Turnaround Time
4 - 7 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Use
For diagnosis and monitoring inflammatory activity in primary systemic small vessel vasculitides. The anti-PR3-ANCA Immunoassay is useful for confirming positive ANCA results by IFA, particularly with the cANCA pattern. Presence of anti-PR3 antibodies is highly specific for Wegener granulomatous (WG) disease, for which the sensitivity is reported to be 98%. Levels of anti-PR3 are elevated during active phases of disease and lower during remission. Monitoring anti-PR3 levels, therefore, can aid in disease management. The anti-MPO-ANCA Immunoassay is useful for confirming positive ANCA results by IFA, particularly with the P-ANCA pattern. Presence of anti-MPO antibodies is highly specific for idiopathic and vasculitis-associated crescentic glomerulonephritis, classic polyarteritis nodosa, Churg-Strauss syndrome, and polyangiitis overlap syndrome without renal involvement. Levels of anti-MPO are elevated during active phases of disease and lower during remission. Therefore, monitoring anti-MPO levels can aid in disease management.
Specimen Requirements
Specimen
Serum
Volume
3 mL
Minimum Volume
1.5 mL (Note: This volume does not allow for repeat testing.)
Container
Red-top tube or gel-barrier tube
Stability Requirements
Temperature | Period |
---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x3 |
Storage Instructions
Room temperature
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
LOINC® Map
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
163061 | ANCA Profile | 163060 | Anti-MPO Antibodies | units | 46266-3 | |
163061 | ANCA Profile | 163068 | Anti-PR3 Antibodies | units | 46267-1 | |
163061 | ANCA Profile | 162400 | Cytoplasmic (C-ANCA) | titer | 14277-8 | |
163061 | ANCA Profile | 162401 | Perinuclear (P-ANCA) | titer | 14278-6 | |
163061 | ANCA Profile | 162402 | Atypical pANCA | titer | 49503-6 | |
Order Code | 163061 | |||||
Order Code Name | ANCA Profile | |||||
Order Loinc | ||||||
Result Code | 163060 | |||||
Result Code Name | Anti-MPO Antibodies | |||||
UofM | units | |||||
Result LOINC | 46266-3 | |||||
Order Code | 163061 | |||||
Order Code Name | ANCA Profile | |||||
Order Loinc | ||||||
Result Code | 163068 | |||||
Result Code Name | Anti-PR3 Antibodies | |||||
UofM | units | |||||
Result LOINC | 46267-1 | |||||
Order Code | 163061 | |||||
Order Code Name | ANCA Profile | |||||
Order Loinc | ||||||
Result Code | 162400 | |||||
Result Code Name | Cytoplasmic (C-ANCA) | |||||
UofM | titer | |||||
Result LOINC | 14277-8 | |||||
Order Code | 163061 | |||||
Order Code Name | ANCA Profile | |||||
Order Loinc | ||||||
Result Code | 162401 | |||||
Result Code Name | Perinuclear (P-ANCA) | |||||
UofM | titer | |||||
Result LOINC | 14278-6 | |||||
Order Code | 163061 | |||||
Order Code Name | ANCA Profile | |||||
Order Loinc | ||||||
Result Code | 162402 | |||||
Result Code Name | Atypical pANCA | |||||
UofM | titer | |||||
Result LOINC | 49503-6 |